These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 27357645)
1. FDG-PET for Prediction of AD Dementia in Mild Cognitive Impairment. A Review of the State of the Art with Particular Emphasis on the Comparison with Other Neuroimaging Modalities (MRI and Perfusion SPECT). Sanchez-Catasus CA; Stormezand GN; van Laar PJ; De Deyn PP; Sanchez MA; Dierckx RA Curr Alzheimer Res; 2017; 14(2):127-142. PubMed ID: 27357645 [TBL] [Abstract][Full Text] [Related]
2. Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers. Xu L; Wu X; Li R; Chen K; Long Z; Zhang J; Guo X; Yao L; J Alzheimers Dis; 2016; 51(4):1045-56. PubMed ID: 26923024 [TBL] [Abstract][Full Text] [Related]
3. Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT. Chiba Y; Iseki E; Fujishiro H; Ota K; Kasanuki K; Suzuki M; Hirayasu Y; Arai H; Sato K Psychiatry Res Neuroimaging; 2016 Mar; 249():105-12. PubMed ID: 26857415 [TBL] [Abstract][Full Text] [Related]
4. The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to Assess Mild Cognitive Impairment in Alzheimer's Disease vs. Dementia with Lewy Bodies. Chiba Y; Fujishiro H; Iseki E; Kasanuki K; Sato K J Neuroimaging; 2019 Nov; 29(6):712-720. PubMed ID: 31199036 [TBL] [Abstract][Full Text] [Related]
5. Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study. Inui Y; Ito K; Kato T; J Alzheimers Dis; 2017; 60(3):877-887. PubMed ID: 28922157 [TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy. Smailagic N; Lafortune L; Kelly S; Hyde C; Brayne C J Alzheimers Dis; 2018; 64(4):1175-1194. PubMed ID: 30010119 [TBL] [Abstract][Full Text] [Related]
7. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting. Iaccarino L; Chiotis K; Alongi P; Almkvist O; Wall A; Cerami C; Bettinardi V; Gianolli L; Nordberg A; Perani D J Alzheimers Dis; 2017; 59(2):603-614. PubMed ID: 28671117 [TBL] [Abstract][Full Text] [Related]
8. Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia. Arbizu J; Prieto E; Martínez-Lage P; Martí-Climent JM; García-Granero M; Lamet I; Pastor P; Riverol M; Gómez-Isla MT; Peñuelas I; Richter JA; Weiner MW; Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1394-405. PubMed ID: 23715905 [TBL] [Abstract][Full Text] [Related]
9. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan]. Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440 [TBL] [Abstract][Full Text] [Related]
10. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia. Trzepacz PT; Yu P; Sun J; Schuh K; Case M; Witte MM; Hochstetler H; Hake A; Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175 [TBL] [Abstract][Full Text] [Related]
11. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion. Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523 [TBL] [Abstract][Full Text] [Related]
12. [ Xue L; Fu Y; Gao X; Feng G; Qian S; Wei L; Li L; Zhuo C; Zhang H; Tian M Eur J Nucl Med Mol Imaging; 2024 Oct; 51(12):3617-3629. PubMed ID: 38839623 [TBL] [Abstract][Full Text] [Related]
13. Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease. Ota K; Oishi N; Ito K; Fukuyama H; ; J Neurosci Methods; 2015 Dec; 256():168-83. PubMed ID: 26318777 [TBL] [Abstract][Full Text] [Related]
14. Concordance between (99m)Tc-ECD SPECT and 18F-FDG PET interpretations in patients with cognitive disorders diagnosed according to NIA-AA criteria. Ito K; Shimano Y; Imabayashi E; Nakata Y; Omachi Y; Sato N; Arima K; Matsuda H Int J Geriatr Psychiatry; 2014 Oct; 29(10):1079-86. PubMed ID: 24687634 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment. Zhang S; Han D; Tan X; Feng J; Guo Y; Ding Y Int J Clin Pract; 2012 Feb; 66(2):185-98. PubMed ID: 22257044 [TBL] [Abstract][Full Text] [Related]
16. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum. Tosun D; Schuff N; Jagust W; Weiner MW; Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336 [TBL] [Abstract][Full Text] [Related]
17. Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI. Ben Bouallègue F; Mariano-Goulart D; Payoux P; J Alzheimers Dis; 2018; 62(1):399-408. PubMed ID: 29439345 [TBL] [Abstract][Full Text] [Related]
18. Multimodal Classification of Mild Cognitive Impairment Based on Partial Least Squares. Wang P; Chen K; Yao L; Hu B; Wu X; Zhang J; Ye Q; Guo X; J Alzheimers Dis; 2016 Aug; 54(1):359-71. PubMed ID: 27567818 [TBL] [Abstract][Full Text] [Related]
19. Biomarker-Based Prediction of Progression to Dementia: F-18 FDG-PET in Amnestic MCI. Tripathi M; Tripathi M; Parida GK; Kumar R; Dwivedi S; Nehra A; Bal C Neurol India; 2019; 67(5):1310-1317. PubMed ID: 31744965 [TBL] [Abstract][Full Text] [Related]
20. Multi-modal discriminative dictionary learning for Alzheimer's disease and mild cognitive impairment. Li Q; Wu X; Xu L; Chen K; Yao L; Li R Comput Methods Programs Biomed; 2017 Oct; 150():1-8. PubMed ID: 28859825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]